“…For example, administration of D-amphetamine boosts amygdalar reactivity to fearful and angry facial expressions, which fits nicely with the finding that dampened amygdalar reactivity in hypodopaminergic Parkinson patients can be restored back to normal levels by administering L-DOPA Tessitore et al, 2002;Kawamura and Kowayakaba, 2009). In sharp contrast, however, administration of L-DOPA and D-amphetamine has also been found to dampen aversive emotional reactions such as amygdalar reactivity to fearful faces and fear-potentiated startle to unpleasant stimuli (Delaveau et al, 2005(Delaveau et al, , 2007(Delaveau et al, , 2009Corr and Kumari, 2013). This apparent inconsistency may be clarified when considering that increasing DA activity through pharmacological interventions only has anxiogenic effects in high-anxiety individuals, whereas in low-anxiety subjects, the same DA increase has an anxiolytic effect (Mizuki et al, 1997).…”